CIK 0001176309 · Pharmaceutical Preparations (SIC 2834) · Nasdaq · incorporated in DE · fiscal year ends 12/31
| FY2025 | FY2024 | FY2023 | FY2021 | |
|---|---|---|---|---|
| Revenue (USD) | 2.0 M | 1.3 M | 2.7 M | 2.7 M |
| Net income (USD) | -36.6 M | -23.0 M | ||
| Diluted EPS (USD/shares) | 1.5 | 0.14 | -0.94 |
| Filed | Form | Description | Period |
|---|---|---|---|
| 2026-10-02 | 4 | 4 | 2026-10-01 |
| 2026-10-02 | 4 | 4 | 2026-10-01 |
| 2026-10-01 | 144 | 144 | |
| 2026-10-01 | 144 | 144 | |
| 2026-09-25 | 4 | 4 | 2026-09-24 |
| 2026-09-25 | 4 | 4 | 2026-09-24 |
| 2026-09-25 | 4 | 4 | 2026-09-24 |
| 2026-09-25 | 4 | 4 | 2026-09-24 |
| 2026-09-17 | 8-K | CURRENT REPORT items 5.07 | 2026-09-15 |
| 2026-08-14 | SCHEDULE 13G/A | SCHEDULE 13G/A | |
| 2026-08-10 | 10-Q | QUARTERLY REPORT | 2026-06-30 |
| 2026-08-03 | ARS | ARS | 2025-12-31 |
| 2026-08-03 | DEFA14A | DEFINITIVE ADDITIONAL MATERIALS | |
| 2026-08-03 | DEF 14A | PROXY STATEMENT | 2026-09-15 |
| 2026-07-22 | SCHEDULE 13D/A | SCHEDULE 13D/A | |
| 2026-07-02 | 4 | OWNERSHIP DOCUMENT | 2026-07-01 |
| 2026-07-02 | 4 | OWNERSHIP DOCUMENT | 2026-07-01 |
| 2026-07-01 | 144 | 144 | |
| 2026-07-01 | 144 | 144 | |
| 2026-06-30 | 8-K | CURRENT REPORT items 5.03,8.01,9.01 | 2026-06-25 |
| 2026-06-29 | SCHEDULE 13G/A | SCHEDULE 13G/A | |
| 2026-06-17 | SCHEDULE 13D/A | SCHEDULE 13D/A | |
| 2026-05-19 | 10-Q | QUARTERLY REPORT | 2026-03-31 |
| 2026-05-15 | NT 10-Q | NOTIFICATION OF LATE FILING | 2026-03-31 |
| 2026-05-15 | SCHEDULE 13G | SCHEDULE 13G |
Forms on file (last 1,000): 8-K 264, 4 251, 10-Q 54, 424B3 40, 3 37, 10-K 17, SC 13G/A 17, 424B5 16. Source: SEC EDGAR, as filed; this page is public data and not investment advice.
GET https://store.agentexchange.work/gw/filings/company?ticker=ORMP (0.002 USD), /gw/filings/filings?ticker=ORMP&form=8-K, /gw/filings/facts?ticker=ORMP&concept=Revenues, full-text /gw/filings/search?q=.... Pay per call in USDC (x402) or with a 19 USD card key for 1,000 calls. Catalogue · llms.txtUpdated from EDGAR within 30 minutes of a filing. Agent Exchange